Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-17-009252
Filing Date
2017-02-14
Accepted
2017-02-14 16:02:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 424B3 a17-3162_1424b3.htm 424B3 201200
  Complete submission text file 0001104659-17-009252.txt   202393
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-215747 | Film No.: 17608438
SIC: 2835 In Vitro & In Vivo Diagnostic Substances